These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 24252944)

  • 21. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
    Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.
    Voltolini L; Bongiolatti S; Luzzi L; Bargagli E; Fossi A; Ghiribelli C; Rottoli P; Gotti G
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e17-23. PubMed ID: 23129356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer.
    Greillier L; Thomas P; Loundou A; Doddoli C; Badier M; Auquier P; Barlési F
    Clin Lung Cancer; 2007 Nov; 8(9):554-61. PubMed ID: 18186960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.
    Sato T; Watanabe A; Kondo H; Kanzaki M; Okubo K; Yokoi K; Matsumoto K; Marutsuka T; Shinohara H; Teramukai S; Kishi K; Ebina M; Sugiyama Y; Meinoshin O; Date H;
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):64-9, 70.e1-2. PubMed ID: 25439777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
    Kim D; Ferraris VA; Davenport D; Saha S
    South Med J; 2015 Apr; 108(4):230-4. PubMed ID: 25871994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer.
    Groth SS; Whitson BA; Kuskowski MA; Holmstrom AM; Rubins JB; Kelly RF
    Lung Cancer; 2009 Jun; 64(3):352-7. PubMed ID: 19019489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we operate on microscopic N2 non-small cell lung cancer?
    Fontaine E; McShane J; Carr M; Shackcloth M; Mediratta N; Page R; Poullis M
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):956-61; discussion 961. PubMed ID: 21330443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?
    Chambers A; Routledge T; Pilling J; Scarci M
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1015-21. PubMed ID: 20354037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
    Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
    Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary sleeve resection in locally advanced lung cancer using cryopreserved allograft for pulmonary artery replacement.
    Berthet JP; Boada M; Paradela M; Molins L; Matecki S; Marty-Ané CH; Gómez-Caro A
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1191-7. PubMed ID: 23953718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications.
    Cerfolio RJ; Talati A; Bryant AS
    Ann Thorac Surg; 2009 Sep; 88(3):930-5; discussion 935-6. PubMed ID: 19699923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.